We are live on ! Find out more
MET icon

MetLife

1,438 hedge funds and large institutions have $41B invested in MetLife in 2026 Q2 according to their latest regulatory filings, with 167 funds opening new positions, 551 increasing their positions, 492 reducing their positions, and 86 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 167 | Existing positions closed: 86

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

20% more capital invested

Capital invested by funds: $34.2B → $41B (+$6.85B)

12% more repeat investments, than reductions

Existing positions increased: 551 | Existing positions reduced: 492

4% more funds holding

Funds holding: 1,3811,438 (+57)

1.26% more ownership

Funds ownership: 74.12%75.37% (+1.3%)

18% less call options, than puts

Call options by funds: $323M | Put options by funds: $396M

Holders
1,438
Holders Change
+57
Holders Change %
+4.13%
% of All Funds
17.37%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
167
Increased
551
Reduced
492
Closed
86
Calls
$323M
Puts
$396M
Net Calls
-$72.6M
Net Calls Change
+$89.6M

MET Hedge Fund Activity: Q2 2026 in Review

1,438 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in MetLife (MET) for Q2 2026, worth a combined $41B — up 20% from $34.2B a quarter earlier.

Buyers outnumbered sellers: 167 funds opened new MET positions and 86 closed out — a net gain of 81 holders — while 551 added to existing stakes and 492 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $219M. The largest seller was Ameriprise, cutting an estimated $265M.

  • 1,438 institutional investors held MetLife (MET) as of Q2 2026, up from 1,381 in Q1 2026.
  • Funds reported $41B of MetLife stock for Q2 2026, up 20% quarter-over-quarter.
  • 167 funds opened new MetLife positions in Q2 2026 and 86 closed out, a net change of +81 holders.
  • The largest MetLife buyer in Q2 2026 was Arrowstreet Capital, an estimated $219M added.
  • The largest MetLife seller in Q2 2026 was Ameriprise, an estimated $265M sold.

Based on aggregated 13F filings for Q2 2026.